E8W-24405-36130
3 vaccinations
6 coded responses
30 check-ins
6 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 265 / WV
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-11
Dose 1 — Pfizer-BioNTech
-
2021-04-01
Dose 2 — Pfizer-BioNTech
-
2021-04-02
Registered in v-safe
- 2021-04-02
-
2021-04-03
Survey response — days 1–6 daily, dose 2MedDRA: Pyrexia — Feeling: Good · Fever · HeadacheFree text: Very low grade feverMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-04
-
2021-04-05
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain, Mobility decreased, Pain in extremity — Feeling: Good · Site: PainFree text: Late last night, and thru most of the night, I experienced relatively strong, very strong pain at the point where I got the shot (injection site). The pain was so severe, almost paralysing, that l almost could not raise my left hand.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-07-01
- 2021-09-30
-
2021-10-05
Dose 3 — Pfizer-BioNTech
- 2021-10-05
-
2021-10-06
Survey response — days 1–6 daily, dose 3MedDRA: Pyrexia — Feeling: Fair · Fever · Muscle or body aches, Fatigue or tirednessFree text: FeverishMedDRA releases: 2024-11 · check-in free text available
-
2021-10-07
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain — Feeling: Poor · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore, Painful lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-08
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Swollen, sore, painful lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-09
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-11
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-11-16
- 2022-01-04
- 2022-04-05
-
2022-10-05
Survey response — 12 months, dose 3MedDRA: Cough, Fatigue, Pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: . Unabating Low-Grade fever . Cough . Fatigue . Achy and painful whole body Beginning late night August 26 2022, through September 4 2022.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Very low grade fever
Systemic reaction (other): Late last night, and thru most of the night, I experienced relatively strong, very strong pain at the point where I got the shot (injection site). The pain was so severe, almost paralysing, that l almost could not raise my left hand.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Feverish
Systemic reaction (other): Sore, Painful lymph node
Systemic reaction (other): Swollen, sore, painful lymph node
Release 12 — 12 months, dose 3
Symptoms: . Unabating Low-Grade fever . Cough . Fatigue . Achy and painful whole body Beginning late night August 26 2022, through September 4 2022.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Injection site pain | ✓ | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Mobility decreased | ✓ | · | ✓ |
| SRO | Pain in extremity | ○ | ✓ | ○ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release